Connor, Clark & Lunn Investment Management Ltd.
Position in MEDP — Medpace Holdings, Inc.
CIK 1596800
VANCOUVER, A1
Position in MEDP
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$58,441,845
-$6,306,014 QoQ
Shares Held
110,353
-18.2% QoQ
Ownership
0.395%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#52
of 691 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MEDP Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Connor, Clark & Lunn Investment Management Ltd. holds $189,818,037 across 16 Diagnostics & Research names. MEDP ranks #1 (30.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MEDP |
Medpace Holdings, Inc.
This page
|
110,353 | $58,441,845 | |
| 2 | GH |
Guardant Health, Inc.
|
215,395 | $32,315,711 | |
| 3 | DHR |
Danaher Corp /De/
|
114,010 | $21,716,624 | |
| 4 | TMO |
Thermo Fisher Scientific Inc.
|
36,269 | $18,183,825 | |
| 5 | NEO |
Neogenomics Inc
|
802,597 | $11,709,889 | |
| 6 | RVTY |
Revvity, Inc.
|
87,145 | $9,695,752 | |
| 7 | MYGN |
Myriad Genetics Inc
|
1,407,860 | $8,038,880 | |
| 8 | CSTL |
Castle Biosciences Inc
|
331,727 | $7,911,688 |
All Filings in MEDP
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $58,441,845 | 110,353 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $64,747,859 | 134,838 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $79,954,247 | 142,356 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $66,120,461 | 128,599 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $49,857,288 | 158,852 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $26,375,794 | 86,566 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $21,733,157 | 65,416 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $8,820,665 | 26,425 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $1,919,632 | 4,661 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $2,628,995 | 6,505 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $2,460,516 | 8,027 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $4,823,229 | 19,920 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $3,353,733 | 13,964 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $568,663 | 3,024 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $5,406,684 | 25,454 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $5,325,548 | 33,884 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $4,754,866 | 31,769 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $3,612,230 | 22,081 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $5,482,569 | 25,191 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $4,068,573 | 21,495 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,644,425 | 9,310 | Shares | Sole | 2021-08-12 | |
| No filing history on record for this holder in this stock. | ||||||